How the RHINO T100 Powers Telehealth and Virtual Care Platforms

Telehealth and virtual care platforms connect patients with clinical teams through video consultations, remote monitoring, and digital care plans. These systems rely on a hardware endpoint, typically a tablet, that patients use at home to access their care platform, transmit vital signs, and communicate with nurses or physicians. For healthcare organizations and their technology partners, the tablet is the physical layer that determines whether a patient can reliably reach their care team, whether protected health information stays secure, and whether a program can scale across thousands of households.

The RHINO T100 is a 10-inch enterprise tablet built specifically for this role. Biofourmis, a digital health company specializing in hospital-at-home programs, selected the T100 as the core hardware component for its patient care platform. The device runs Android Enterprise, supports mobile device management (MDM) through platforms like Mambo EMM, and receives security updates on a 90-day cycle. For telehealth deployments, this matters because the tablet must remain compliant with healthcare regulations throughout its entire service life while requiring minimal hands-on attention from patients or field staff.

Healthcare IT directors, telehealth platform vendors, and hospital operations leaders should care about this hardware decision because the wrong tablet introduces unpredictability. A device that lacks guaranteed availability, controlled update timing, or enterprise-grade remote management forces clinical engineering teams into reactive support work. When a patient cannot join a scheduled video visit because their device failed or dropped connectivity, the care plan stalls and the clinical team loses visibility.

The Tablet Becomes the Care Environment

In hospital-at-home programs, the tablet is the patient's primary interface with the healthcare system. They use it for video visits with physicians, to review medication instructions, to acknowledge alerts from remote monitoring devices, and sometimes to transmit biometric data from connected peripherals. The device must be immediately usable by patients who may have limited technical experience and varying home network conditions.

The RHINO T100 addresses this through purpose-built enterprise hardware. The 10-inch form factor accommodates older patients or those with vision limitations. Android Enterprise provides a managed environment where the telehealth application can be locked as the primary interface, reducing the chance of patients navigating away from critical functions or installing unauthorized software.

Biofourmis integrated the T100 into its hospital-at-home kits alongside the KORE Super SIM for connectivity. This combination allows automatic carrier switching when a patient's home has weak coverage from one network but stronger signal from another. For remote patient monitoring (RPM) platforms, this resilience matters because gaps in data transmission can trigger false alerts or mask genuine clinical deterioration.

Security Updates Are a Clinical Dependency

Healthcare data security directly affects whether a telehealth program maintains its regulatory standing and patient trust. The Health Insurance Portability and Accountability Act (HIPAA) and related frameworks require reasonable safeguards for electronic protected health information. When a tablet runs outdated Android versions with unpatched vulnerabilities, the organization assumes liability.

The RHINO T100 receives security updates every 90 days, managed through Android Enterprise. This predictable cadence allows telehealth platform teams to test compatibility before updates deploy, rather than reacting to unexpected automatic updates that might break critical integrations. For Biofourmis, this control was essential because an update that disrupted their RPM platform would have interrupted patient monitoring across the entire deployment.

Healthcare IT teams evaluating tablets for telehealth should verify that a device's update schedule is committed, published, and compatible with their MDM infrastructure. Ask vendors for their security bulletin history and their policy on Android version migration. A device that launches on a current Android version but receives no upgrade path will become a compliance risk before the hardware itself fails.

Guaranteed Availability Enables Program Planning

Telehealth platforms require hardware consistency. When a healthcare organization trains field staff on a specific device, documents patient setup procedures, and integrates peripherals around a particular port configuration or Android version, changing hardware mid-program creates operational disruption.

The RHINO T100 carries a guaranteed minimum three-year availability commitment. This means healthcare organizations can standardize their hospital-at-home kits, spare pools, and training materials without fear that their hardware will be discontinued after 18 months. For procurement teams, this predictability supports multi-year budgeting and reduces the risk of forced hardware transitions that require re-certification with clinical platforms.

Biofourmis reported a 45% savings on total cost of ownership (TCO) after standardizing on the T100, alongside a 70% reduction in readmissions for acute-at-home care programs and 16,000 saved hospital bed days. While outcomes depend on the full care model, the hardware standardization removed variables that previously consumed clinical engineering resources.

Connectivity Design for Home Environments

Patient homes present network conditions that differ dramatically from clinical facilities. Wi-Fi may be outdated, shared with multiple family members, or intermittently powered down. Cellular connectivity provides a necessary backup, but not all tablets support the same carrier bands or management features.

The T100's integration with multi-carrier SIM solutions allows the device to maintain connection without requiring patients to troubleshoot network selection. For platform vendors, this means fewer support calls and more complete data sets. For clinical teams, it means video visits start on schedule and monitoring alerts transmit without delay.

Organizations evaluating telehealth hardware should test connectivity behavior in realistic home conditions, not just clinical demonstration environments. Verify whether the device supports the carriers with strongest coverage in your patient population's geography, and whether network switching requires manual intervention.

When Consumer Tablets Enter the Conversation

Some telehealth programs initially consider consumer tablets for cost reasons. This path can work for small pilots or voluntary bring-your-own-device programs. Scaling beyond dozens of patients typically exposes limitations that affect clinical operations.

Consumer tablets lack guaranteed availability, which forces hardware refreshes that fragment the device fleet. They receive updates on manufacturer schedules that prioritize consumer features over enterprise stability. They do not support Android Enterprise features like zero-touch enrollment, which means each device requires manual setup before reaching a patient. For a program shipping hundreds of kits monthly, this manual work becomes a bottleneck.

The decision framework differs by program stage. Early pilots may accept consumer hardware to validate clinical models. Mature programs serving thousands of patients benefit from the standardization, remote management, and lifecycle predictability that enterprise tablets provide.

Frequently Asked Questions

What Android version does the RHINO T100 run for telehealth deployments?

The T100 runs Android Enterprise, which provides the management APIs and security frameworks that telehealth platforms require. Your MDM platform can lock the device to approved applications, enforce encryption, and control update deployment. Verify the current Android version with Rhino Mobility, as enterprise devices maintain committed upgrade paths.

How does the 90-day security update cycle work in practice?

Rhino Mobility publishes security patches on a quarterly cycle. IT teams receive advance notice, allowing compatibility testing with their telehealth platform before staged rollout. This predictability prevents the disruption that occurs when consumer devices install updates automatically and break clinical application functionality.

Can the T100 integrate with existing remote patient monitoring peripherals?

The T100 supports standard Android connectivity protocols including Bluetooth and USB, enabling integration with pulse oximeters, blood pressure cuffs, weight scales, and other biometric devices. Platform vendors should validate specific peripheral combinations during pilot testing, as Android Enterprise management policies may affect how peripherals pair and transmit data.

What is zero-touch enrollment, and why does it matter for hospital-at-home programs?

Zero-touch enrollment allows IT to pre-configure devices before they ship to patients. When the patient powers on the tablet, it automatically applies settings, installs the telehealth application, and enforces security policies without requiring technical staff to visit the home or walk the patient through setup. This reduces deployment cost and setup errors at scale.

How does guaranteed three-year availability affect procurement planning?

Healthcare organizations can standardize on a single device SKU for the full program duration, maintaining consistent spare pools, training materials, and peripheral compatibility. Procurement teams avoid mid-program hardware transitions that require re-validation with clinical platforms and re-training of field staff.

Build Your Telehealth Platform on Predictable Hardware

Telehealth programs succeed when clinical teams can focus on patients rather than device management. The RHINO T100 provides the enterprise foundation that makes this possible: committed security updates, guaranteed hardware availability, and resilient connectivity designed for unpredictable home environments.

Biofourmis demonstrated how this approach scales, integrating the T100 as the hardware core for a hospital-at-home program serving thousands of patients with measurable clinical and operational outcomes.

If your organization is evaluating hardware for telehealth, remote patient monitoring, or virtual care platforms, Rhino Mobility can provide detailed specifications, carrier certification information, and integration guidance for the RHINO T100 tablet. For organizations requiring 5G connectivity or larger display formats, the RHINO T105 offers an expanded feature set within the same enterprise platform. Learn more about Android Enterprise Recommended devices and how they support healthcare deployments, or review the Biofourmis hospital-at-home case study for a detailed implementation example.